The UvA and Johan Cruijff ArenA started a partnership that aims to increase the societal impact of research in society with joint research projects. The Johan Cruijff ArenA is a vibrant innovative organization and one of the most exciting living labs in the Netherlands.
Right from the outset of the Johan Cruijff ArenA’s innovation platform the UvA has been involved in some interesting research regarding crowd management and network systems. UvA will seek to broaden the existing collaboration into other fields in which the UvA has expertise, such as sustainability, artificial intelligence, mobility and behavioural sciences. IXA-UvA invites UvA researchers to discuss potential research projects for this living lab. The HvA has preceded us with several research collaborations, and they are very enthusiastic about the opportunities a living lab such as the ArenA is offering. So if your research fits one of the six themes: Smart Building & City, Visitor Engagement, Safety & Security, Sports & Health, Sustainability, or equal Education & Employment, please contact the IXA-UvA office.
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
NewsPULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News